Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Mindset Pharma Inc.
  6. Summary
    MSET   CA60268M1023

MINDSET PHARMA INC.

(MSET)
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Canadian National Stock E…
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
0.85(c) 0.92(c) 0.89(c) 0.9(c) 0.85 Last
219 243 261 667 118 467 130 715 290 335 Volume
-4.49% +8.24% -3.26% +1.12% -5.56% Change
More quotes
Estimated financial data (e)
Sales 2019
Net income 2019
Net Debt 2019
P/E ratio 2019
Yield 2019
Sales 2020 - - -
Net income 2020 -0,64 M -0,50 M -0,50 M
Net cash position 2020 0,54 M 0,42 M 0,42 M
P/E ratio 2020 -
Yield 2020 -
Capitalization 78,2 M 61,3 M 61,3 M
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees -
Free-Float -
More Financials
Company
Mindset Pharma Inc is a Canada-based psychedelic-based drug discovery company. The Company is focused on developing psychedelic compounds for treatment-resistant neurological and psychiatric disorders. 
Sector
Biotechnology & Medical Research
Calendar
09/21 | 02:05pmPresentation
More about the company
All news about MINDSET PHARMA INC.
09/14MINDSET PHARMA : Further Validates Lead Candidate as Next Generation Psilocybin ..
MT
09/14MINDSET PHARMA : Further Validates Lead Candidate, MSP-1014, as a Next Generatio..
AQ
09/09Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer ..
GL
09/07Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies..
GL
09/07Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies..
CI
09/02MINDSET PHARMA : to Participate in Upcoming Investor Conferences in September 20..
AQ
08/31Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic Anal..
GL
08/31Mindset Pharma Inc. Announces Next Generation Novel 5-Meo-Dmt Psychedelic Ana..
CI
08/26MINDSET PHARMA : Announces Preclinical Results Demonstrating Extended Duration o..
AQ
08/26Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration ..
CI
08/24MINDSET PHARMA : Broadens its IP Portfolio by Filing U.S. Provisional Patent Ext..
AQ
08/24Mindset Pharma Inc. Files its New Provisional Patent Application with the Uni..
CI
08/16MINDSET PHARMA : Announces Publication of Three PCT Patent Applications for Its ..
AQ
08/16Mindset Pharma Announces Publication of Three PCT Patent Applications for Its..
CI
08/10Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy,..
GL
More news
News in other languages on MINDSET PHARMA INC.
09/14MINDSET PHARMA INC. : Mindset Pharma liefert durch Drug Discrimination Assay wei..
09/14MINDSET PHARMA INC. : Mindset Pharma liefert durch Drug Discrimination Assay wei..
09/09MINDSET PHARMA INC. : Mindset Pharma wählt therapieresistente Depressionen und A..
09/09MINDSET PHARMA INC. : Mindset Pharma wählt therapieresistente Depressionen und A..
09/07MINDSET PHARMA INC. : Mindset Pharma entwickelt hochspezialisierte präklinische ..
More news
Chart MINDSET PHARMA INC.
Duration : Period :
Mindset Pharma Inc. Technical Analysis Chart | MSET | CA60268M1023 | MarketScreener
Income Statement Evolution
Managers and Directors
James Andre Charles Lanthier Chief Executive Officer
Arvin Ramos Chief Financial Officer
Richard J. Patricio Chairman
Joseph Araujo Director & Chief Science Officer
James Christopher Passin Director
Sector and Competitors
1st jan.Capi. (M$)
MINDSET PHARMA INC.-4.26%62
MODERNA, INC.321.80%177 867
LONZA GROUP AG36.36%62 278
IQVIA HOLDINGS INC.43.91%49 407
CELLTRION, INC.-23.26%31 021
SEAGEN INC.-12.32%27 940